Orphazyme board on CEO changes: She had an old-fashioned management style
Kim Stratton preferred leaving the role of CEO at Orphazyme over fulfilling the board of directors' requirements that she include the board and executive team in her decisions, says Vice Chair Bo Jesper Hansen. "Some would call her management style very American, but I think it's more that; it's old-fashioned," he says.
BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN
On Thursday, the biotech firm Orphazyme announced that the CEO Kim Stratton would no longer be working at the firm after serving for just one year and two months, but she was not fired.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
